View Post

‘Double decker’ antibody technology fights cancer

In In The News by Barbara Jacoby

Source: Scripps Research Institute From: Scientists from the Florida campus of The Scripps Research Institute (TSRI) have created a new class of antibody-drug conjugates (ADCs), using a versatile “double decker” technology that ties antibodies and a drug together to produce highly potent pharmaceuticals for cancer therapy. The new ADC technology advances a class of pharmaceuticals that use antibodies to …